Ce don permettra de soutenir les efforts de dépistage afin de garantir un accès continu aux services essentiels pour les enfants et leurs familles. Paris, France et Camberley, Royaume-Uni – 4 mai 2021 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, fera un don d’un million de tests
Visit PageYear: 2021
Novacyt to support UNICEF with donation of one million COVID-19 tests
Donation supports testing efforts to help ensure continued access to essential services for children and their families Paris, France and Camberley, UK – 4 May 2021 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT; “Novacyt”), an international clinical diagnostics company, will donate one million COVID-19 polymerase chain reaction (PCR) tests to UNICEF to help contain
Visit PageR&D and UK operational update
Paris, France and Camberley, UK – 23 April 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its near-term COVID-19 research and development (R&D) programmes to address rapidly evolving testing demands, particularly as SARS-CoV-2 continues to mutate around the world. Novacyt also provides
Visit Page